FDA.reportPublic FDA data

Carimune

Product NDC
44206-417
Requested package NDC
44206-417-06
11-digit product format
442060417
Labeler code
44206
Product ID
44206-417_6d78337d-6fba-4156-a522-1c03c9181489
Type
PLASMA DERIVATIVE
Nonproprietary name
HUMAN IMMUNOGLOBULIN G
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
CSL Behring AG
Application
BLA102367
Marketing category
BLA
Marketing start
2009-02-10
Marketing end
2021-05-31
Substance
HUMAN IMMUNOGLOBULIN G
Active strength
6 g/1
Pharmacologic classes
Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage44206-41744206-417-06DDiscontinued by firm2026-08-03

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
44206-417-06EA - Each44206-4176036f516-6c01-4c02-a1db-825270b3031312012-07-24
44206-417-91EA - Each44206-4171081cc44-48f8-419d-a2fe-027a6630a6d612017-03-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSCARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG]8
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSCARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG]8
Sodium ChlorideINACTIVE INGREDIENT451W47IQ8XCARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG]8
SucroseINACTIVE INGREDIENTC151H8M554CARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG]8

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
102367Carimune, Carimune Nf, Panglobulin, SandoglobulinImmune Globulin Intravenous (Human)351(a)Disc2026-06-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
44206-417-06442060417061 VIAL, SINGLE-USE in 1 CARTON (44206-417-06) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-417-91) 2009-02-102021-05-31NoNoCurrent